Cell & Gene Therapy Strategy Meeting Switzerland 2019 | Proventa International
Website https://proventainternational.com/cell-and-gene-therapy-eu-2019/ |
Edit Freely
Category Cell Therapy, Immune Deficiencies, Cell Engineering, CAR-TBiotherapeutics, Cellular Immunotherapy, Regenerative Medicine, Supply Chain and Manufacturing
Deadline: October 09, 2019 | Date: October 09, 2019
Venue/Country: Radisson Blu Hotel, Zurich Airport, Switzerland
Updated: 2019-07-30 16:43:29 (GMT+9)
Call For Papers - CFP
Proventa International’s unique format of Cell & Gene Therapy Strategy Meeting Switzerland 2019 gathers seasoned local and global thought leaders in an exclusive discussion where director-level professionals share knowledge and insights on key strategic challenges. This year's Cell & Gene Therapy Strategy Meeting will be held at Radisson Blu Hotel, Zurich Airport on October 9, 2019. For more information, visit https://proventainternational.com/cell-and-gene-therapy-eu-2019/
.Who should attend?Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:Cell Therapy, Immune Deficiencies, Cell Engineering, CAR-TBiotherapeutics, Cellular Immunotherapy, Regenerative Medicine, Supply Chain and ManufacturingSubmit your interest to attend, sponsor or partner!Delegate Registration: kmj
proventainternational.com Sponsorship Opportunities: infoproventainternational.comMedia Partnership: mediaproventainternational.comTo see other strategy meetings near you, please visit https://proventainternational.com/strategy-meetings/.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.